Skip to main content
. 2020 May 26;11(21):1961–1970. doi: 10.18632/oncotarget.27606

Figure 3. The efficacy of TAK1 inhibition on cell death is characterized by TAK1KO, as well as takinib + TNF treatment.

Figure 3

(A) An apoptosis protein array revealed that in comparison to TAK1WT (with Cas9 vehicle), TAK1KO upregulated several apoptotic proteins. (B) Despite some similarities in apoptotic biomarkers, TAK1KO were significantly more sensitive to apoptosis following TNF (30 ng/mL) treatments. (C) Apoptotic protein expression in TAK1mediated TNF apoptosis. (D) Differences in protein levels were evident in TAK1KO vs. TAK1KO with TNF proteome assays. (E) Compared to TNF and takinib + TNF treatments, TAK1KO cells that were treated with vehicle, had significant upregulation of Hsp60, Cleaved Caspase-3 and SMAC. Two-way ANOVA.